AMC - BB AMC SKLZ and SRNE among premarket gainers
BriaCell Therapeutics (BCTX) +102% after update on the overall survival data of advanced breast cancer patients.Constellation Pharmaceuticals (CNST) +67% on merger agreement with MorphoSys.Stealth BioTherapeutics (MITO) +46% on EMA orphan drug status for elamipretide.AC Immune SA (ACIU) +19% after update on Alzheimer’s disease Vaccine Candidates.AMC Entertainment Holdings (AMC) +19% after announcing AMC Investor Connect for retail investors.Soleno Therapeutics (SLNO) +15% on receiving Orphan Drug designation from FDA for Diazoxide Choline.Lyra Therapeutics (LYRA) +16% on partnership with LianBio.BlackBerry (BB) +13%.9F (JFU) +11%.RLX Technology (RLX) +11% on Q1 results.SCYNEXIS (SCYX) +8% as FDA approved its BREXAFEMME.Torchlight Energy Resources (TRCH) +10%.Ashford Hospitality Trust (AHT) +10%.SCWorx Corp. (WORX) +10% as it regains Nasdaq compliance.SRAX (SRAX) +8%.Clearside Biomedical (CLSD) +8% after Bausch Health and the Company announce FDA filing acceptance for XIPERE™.Exela Technologies, Inc. (XELA) +7%.MicroVision, Inc. (MVIS) +8%.Skillz Inc. (SKLZ) +7% on Aarki acquisition.Koss Corporation (KOSS) +7%.Immutep Limited (IMMP) +6% on collaboration with Merck KGaA in solid tumors.Washington Prime Group (WPG) +6%.Performant Financial Corporation (PFMT) +6%.Sorrento Therapeutics, Inc.
For further details see:
BB, AMC, SKLZ and SRNE among premarket gainers